![Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and](https://ars.els-cdn.com/content/image/1-s2.0-S0002870317301242-gr1.jpg)
Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and
![Safety and Efficacy of Antiplatelet and Antithrombotic Therapy in Acute Coronary Syndrome Patients With Chronic Kidney Disease | Journal of the American College of Cardiology Safety and Efficacy of Antiplatelet and Antithrombotic Therapy in Acute Coronary Syndrome Patients With Chronic Kidney Disease | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/5b7a8e75-91c8-4514-97cf-494e70363d55/gr1.jpg)
Safety and Efficacy of Antiplatelet and Antithrombotic Therapy in Acute Coronary Syndrome Patients With Chronic Kidney Disease | Journal of the American College of Cardiology
Inclusion of participants in analysis and chronic kidney disease (CKD)... | Download Scientific Diagram
![Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial | BMJ Open Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/4/2/e004886/F1.large.jpg)
Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial | BMJ Open
![Frontiers | Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways Frontiers | Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways](https://www.frontiersin.org/files/Articles/639592/fendo-12-639592-HTML/image_m/fendo-12-639592-g001.jpg)
Frontiers | Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways
![Healthcare | Free Full-Text | Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection Healthcare | Free Full-Text | Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection](https://www.mdpi.com/healthcare/healthcare-09-01484/article_deploy/html/images/healthcare-09-01484-g001-550.jpg)
Healthcare | Free Full-Text | Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection
![The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-92753-4/MediaObjects/41598_2021_92753_Fig1_HTML.png)
The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment | Scientific Reports
![Applied Sciences | Free Full-Text | The Gastrointestinal Microbiota as a Potential Cause and Target in Chronic Kidney Disease Accentuating Treatment and Intervention Strategies Applied Sciences | Free Full-Text | The Gastrointestinal Microbiota as a Potential Cause and Target in Chronic Kidney Disease Accentuating Treatment and Intervention Strategies](https://www.mdpi.com/applsci/applsci-13-03212/article_deploy/html/images/applsci-13-03212-g001.png)
Applied Sciences | Free Full-Text | The Gastrointestinal Microbiota as a Potential Cause and Target in Chronic Kidney Disease Accentuating Treatment and Intervention Strategies
![Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease and low bodyweight: results from KNOW-CKD study | Scientific Reports Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease and low bodyweight: results from KNOW-CKD study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-86192-4/MediaObjects/41598_2021_86192_Fig1_HTML.png)
Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease and low bodyweight: results from KNOW-CKD study | Scientific Reports
![PDF] Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease | Semantic Scholar PDF] Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/38e01de7594a479687878c52e473ebef9958321f/2-Figure1-1.png)
PDF] Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease | Semantic Scholar
![Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial | Chinese Medical Journal Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial | Chinese Medical Journal](https://mednexus.org/cms/asset/efb09dc7-fce2-449c-991a-0face54edde5/cm9.0000000000002574.png)
Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial | Chinese Medical Journal
![Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S008525382030973X-fx1.jpg)
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease - ScienceDirect
![Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke. | Semantic Scholar Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6e12c9d0df9f5fa4df4005974f6bf40d350780d7/2-Figure1-1.png)
Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke. | Semantic Scholar
![Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke - ScienceDirect Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0953620516304058-gr1.jpg)